This is a new treatment6 May 2020 14:09
I know we live in a world of instant gratification, and I am not a medical expert, but it does strike me that some seem to have developed an unreasonable expectation around the development timeframe of a new drug. Testing is critical, but think about it - some people have needed 5,6 or 7 tests to get an accurate reading from an 'approved' test. Now, imagine what would happen if there were unintended consequences of taking a drug because it had not been trialled properly with the same level of 'inaccuracy' or possible side effects They cannot and I believe will not cur corners and I firmly believe they cannot go quicker than they are - they know the prize that is at stake both commercially and with regards to human lives. Also remember, this is also about trying to help patients not just for covid19, but also patients who are vulnerable from lung issues with a who range or viruses - so there is also a long term transformational drug at stake here. So, in my opinion, let them get on with it, don't expect them to RNS every single bit of detail - they will update as soon as is possible with firm news. No amount of suggesting they provide an update to stop share price declines is going to make this trial go any faster. All IMO and GLA invested.